Literature DB >> 2563671

Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.

T Suzuki1, J Yokota, H Mugishima, I Okabe, M Ookuni, T Sugimura, M Terada.   

Abstract

Using 29 polymorphic DNA markers which detect allelic deletion of genes at specific loci on 19 different chromosomes, we analyzed 14 neuroblastomas for possible loss of chromosomal heterozygosity. The incidence of loss of heterozygosity was high at the D14S1 locus on chromosome 14q, being detected in six of 12 patients (50%). In spite of the cytogenetic finding suggesting high frequency of chromosome 1p deletion, loss of heterozygosity at the MYCL locus on 1p32 was detected only in two of nine patients (22%). It was also found in two of 11 patients (18%) on 13q, but not on chromosomes 2, 3, 5, 6, 7, 8, 9, 10, 11, 12, 15, 16, 17, 18, 19, and 20. The present results indicate that recessive genetic changes involving sequences on chromosome 14q may play an important role in the development of neuroblastoma.

Entities:  

Mesh:

Year:  1989        PMID: 2563671

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Search for neuroblastoma loci: characterization of tumor cell lines that could facilitate their positional cloning.

Authors:  M Romani; R Muresu; E V Volpi; C Rozzo; J M Marchi; I Casciano
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

2.  Loss of heterozygosity for alleles on chromosome II in cervical carcinoma.

Authors:  E S Srivatsan; B C Misra; M Venugopalan; S P Wilczynski
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

Review 3.  Neuroblastoma tumour genetics: clinical and biological aspects.

Authors:  N Bown
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.

Authors:  Nicolas Aznar; Krishna K Midde; Ying Dunkel; Inmaculada Lopez-Sanchez; Yelena Pavlova; Arthur Marivin; Jorge Barbazán; Fiona Murray; Ulrich Nitsche; Klaus-Peter Janssen; Karl Willert; Ajay Goel; Miguel Abal; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

5.  Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.

Authors:  H Caron; P van Sluis; R Buschman; R Pereira do Tanque; P Maes; L Beks; J de Kraker; P A Voûte; G Vergnaud; A Westerveld; R Slater; R Versteeg
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

Review 6.  Biology of tumors of the peripheral nervous system.

Authors:  G M Brodeur; J F Moley
Journal:  Cancer Metastasis Rev       Date:  1991-12       Impact factor: 9.264

7.  The human homologue of the retroviral oncogene qin maps to chromosome 14q13.

Authors:  K Kastury; J Li; T Druck; H Su; P K Vogt; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 8.  Genetics of cancer predisposition and progression.

Authors:  K Schwechheimer; W K Cavenee
Journal:  Clin Investig       Date:  1993-06

9.  Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma.

Authors:  Eva Villamón; Marta Piqueras; Carlos Mackintosh; Javier Alonso; Enrique de Alava; Samuel Navarro; Rosa Noguera
Journal:  Virchows Arch       Date:  2008-06-24       Impact factor: 4.064

10.  Constitutional 1p36 deletion in a child with neuroblastoma.

Authors:  J A Biegel; P S White; H N Marshall; M Fujimori; E H Zackai; C D Scher; G M Brodeur; B S Emanuel
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.